| Code | CSB-RA005386MA1HU |
| Size | US$210 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
| Application | Recommended Dilution |
|---|---|
| IHC | 1:50-1:200 |
CHRNA1, the alpha-1 subunit of the nicotinic acetylcholine receptor, plays a fundamental role in neuromuscular transmission. Located at the neuromuscular junction, this receptor subunit is essential for converting chemical signals from motor neurons into muscle contraction. Researchers investigating neuromuscular disorders, including congenital myasthenic syndromes and myasthenia gravis, rely on precise detection of CHRNA1 to understand disease mechanisms and evaluate therapeutic approaches. The receptor's involvement in neurophysiological processes also makes it relevant to broader neuroscience investigations.
This recombinant monoclonal antibody, clone 27G9, offers the reproducibility that demanding research protocols require. Because recombinant antibodies are produced from defined genetic sequences rather than traditional hybridoma methods, you can expect consistent performance across experiments and between lots. This sequence-defined production eliminates the variability that can compromise longitudinal studies or multi-site collaborations, giving you confidence that your results reflect true biological differences rather than reagent inconsistency.
Validation in immunohistochemistry demonstrates clear detection in paraffin-embedded human skeletal muscle tissue, which represents a physiologically relevant sample type given CHRNA1's established expression at the neuromuscular junction. The recommended working dilution of 1:50 to 1:200 provides flexibility to optimize signal intensity based on your specific tissue preparation and detection system. The antibody has also been validated for ELISA applications, expanding its utility across different experimental workflows.
For researchers exploring neuromuscular biology, receptor pharmacology, or the molecular basis of myasthenic conditions, this antibody provides a reliable tool for detecting CHRNA1 in human samples with the consistency that recombinant technology delivers.
There are currently no reviews for this product.